Methods. We investigated the relationship between circulating NPY and the progression of the glomerular filtration rate (GFR) and proteinuria and the risk for a combined renal endpoint (>30% GFR loss, dialysis/transplantation) in two European chronic kidney disease (CKD) cohorts including follow-up of 753 and 576 patients for 36 and 57 months, respectively.
Background. Neuropeptide Y (NPY) is a sympathetic neurotransmitter that has been implicated in various disorders including obesity, gastrointestinal and cardiovascular diseases.
Neuropeptide Y and chronic kidney disease progression: a cohort study
Zoccali Carmine;D'Arrigo Graziella;Leonardis Daniela;Pizzini Patrizia;Tripepi Giovanni;Mallamaci Francesca;
2018
Abstract
Background. Neuropeptide Y (NPY) is a sympathetic neurotransmitter that has been implicated in various disorders including obesity, gastrointestinal and cardiovascular diseases.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prod_397790-doc_174036.pdf
solo utenti autorizzati
Descrizione: Neuropeptide Y and chronic kidney disease progression: a cohort study
Tipologia:
Versione Editoriale (PDF)
Dimensione
337.14 kB
Formato
Adobe PDF
|
337.14 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
